SPARK-CGM Program Expands CGM Access in Primary Care
ClinicalTrials.gov Studies
Summary
The SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) implementation study (NCT07548372) aims to increase access to continuous glucose monitoring (CGM) technology in primary care settings. Investigators at Montefiore Medical Center will support primary care providers with education, tools, and resources to incorporate CGM into routine diabetes care. The study will evaluate whether the SPARK-CGM program increases CGM prescriptions among eligible patients with diabetes.
“The investigators aim to make CGM more accessible and equitably prescribed in primary care practices.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov registry entry documents the SPARK-CGM implementation study, a clinical research initiative designed to make continuous glucose monitoring technology more accessible and equitably prescribed in primary care practices. The program provides primary care providers with education, tools, and support to incorporate CGM into routine diabetes management across Montefiore Medical Center's primary care network.
Healthcare providers and researchers interested in diabetes care delivery may wish to monitor findings from this program evaluation, as results could inform future CGM adoption strategies in similar primary care settings. The study compares enhanced CGM interventions against standard of care.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SPARK-CGM Implementation
N/A NCT07548372 Kind: NA Apr 23, 2026
Abstract
Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primary care settings, where most people receive their diabetes care. The investigators aim to make CGM more accessible and equitably prescribed in primary care practices. The study team will support primary care to increase CGM use with a program called SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) across a large network of primary care clinics at Montefiore Medical Center. This program will provide primary care providers (PCPs) with education, tools, and support to incorporate CGM into their routine care for people with diabetes. Investigators plan to test SPARK-CGM to evaluate whether it increases CGM prescriptions who are eligible to receive this technology.
Conditions: Diabetes Mellitus
Interventions: Enhanced CGM Interventions, Standard of Care
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.